Moludi Jalal, Saber Amir, Zozani Morteza Arab, Moradi Shima, Azamian Yasaman, Hajiahmadi Salimeh, Pasdar Yahya, Moradi Fardin
Department of Nutritional Sciences, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah 6719851552, Iran.
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah 6719851552, Iran.
Prev Nutr Food Sci. 2024 Sep 30;29(3):237-255. doi: 10.3746/pnf.2024.29.3.237.
Patients with gastrointestinal (GI) disorders might benefit from probiotic supplementation to resolve their bowel symptoms and enhance their quality of life (QoL). This systematic review aimed to evaluate the effects of oral probiotic supplementation on improving QoL. Relevant studies were systematically searched in online databases, including PubMed, Scopus, Embase, ProQuest, and Google Scholar up to September 2022 using relevant keywords. Studies that were conducted on GI patients and presented QoL outcomes were included. The Revised Cochrane Risk of Bias 2 tool and the Risk Of Bias In Non-randomized Studies of Intervention tool were used to assess the risk of bias. Of the 4,555 results found in the systematic search of databases, only 36 studies were eligible for evaluation. According to this systematic review, 24 studies reported improvements, whereas 12 studies reported no improvements on QoL in GI patients supplemented with probiotics. We found that probiotics may improve the QoL of patients with GI diseases and related metabolic complications. Therefore, probiotics can be a useful supportive treatment strategy in these patients.
患有胃肠道(GI)疾病的患者可能会从补充益生菌中受益,以缓解肠道症状并提高生活质量(QoL)。本系统评价旨在评估口服补充益生菌对改善生活质量的影响。使用相关关键词,在包括PubMed、Scopus、Embase、ProQuest和谷歌学术在内的在线数据库中系统检索了截至2022年9月的相关研究。纳入了对胃肠道疾病患者进行的并呈现生活质量结果的研究。使用修订的Cochrane偏倚风险2工具和干预非随机研究中的偏倚风险工具来评估偏倚风险。在数据库的系统检索中找到的4555项结果中,只有36项研究符合评估条件。根据本系统评价,24项研究报告了改善情况,而12项研究报告补充益生菌的胃肠道疾病患者的生活质量没有改善。我们发现益生菌可能会改善患有胃肠道疾病和相关代谢并发症患者的生活质量。因此,益生菌可以成为这些患者有用的辅助治疗策略。